Review
[Myelodysplastic syndrome]
[Article in
Japanese]
Affiliations
- PMID: 15791810
Item in Clipboard
Review
[Myelodysplastic syndrome]
[Article in
Japanese]
Gan To Kagaku Ryoho.
2005 Mar.
Abstract
Myelodysplastic syndrome (MDS) is a heterogenous syndrome which has features of refractory anemia and preleukemic state due to the ineffective hematopoiesis of bone marrow cells. MDS is classified by the FAB classification and/or WHO classification, and has an International Prognostic Scoring System (IPSS) for evaluation of the prognosis. Available therapies consist of a variety of modalities from supportive therapy to hematopoietic stem cell transplantation, and are selected according to the condition of each patient.
Similar articles
-
Refractory anemia and the myelodysplastic syndromes.Clin Lab Sci. 2004 Summer;17(3):178-86. Clin Lab Sci. 2004. PMID: 15314893 Review.
-
Factors influencing survival in myelodysplastic syndromes in a Brazilian population: comparison of FAB and WHO classifications.Leuk Res. 2004 Jun;28(6):587-94. doi: 10.1016/j.leukres.2003.11.001. Leuk Res. 2004. PMID: 15120935
-
Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.Ann Hematol. 2006 Aug;85(8):502-13. doi: 10.1007/s00277-005-0030-z. Epub 2006 May 20. Ann Hematol. 2006. PMID: 16715299
-
Classification and scoring systems in myelodysplastic syndromes: a retrospective analysis of 311 patients.Leuk Res. 2006 Aug;30(8):971-7. doi: 10.1016/j.leukres.2005.11.015. Epub 2006 Jan 19. Leuk Res. 2006. PMID: 16423393
-
The myelodysplastic syndromes: classification and prognosis.Curr Hematol Rep. 2003 May;2(3):179-85. Curr Hematol Rep. 2003. PMID: 12901338 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous
